A SADS defect in tumor cells provides optimism.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 11135609.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
SADS, a new component of the Fas-mediated apoptotic pathway, is downregulated in patients with colon carcinoma. Could this downregulation be a widespread mechanism of tumor cell immune invasion?
Medical subject headings
- Colonic Neoplasms
- Neoplasm Proteins